Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Retatrutide vs Mounjaro (Tirzepatide): Which is Better? Cagrilintide and semaglutide together drive record weight loss in global trial What is the pipeline for future medications for obesity? International Journal of Obesity EASD 2023: meta analysis shows tirzepatide superiority to semaglutide Clinical Trials Arena Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination